Literature DB >> 17236200

Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma.

Kai Neben1, German Ott, Silja Schweizer, Jörg Kalla, Björn Tews, Tiemo Katzenberger, Meinhard Hahn, Andreas Rosenwald, Anthony D Ho, Hans Konrad Müller-Hermelink, Peter Lichter, Alwin Krämer.   

Abstract

In mantle cell lymphoma (MCL), a blastoid variant with a striking tendency to harbor chromosome numbers in the tetraploid range has been identified. Centrosome aberrations have recently been implicated in the induction of aneuploidy in many human malignancies including MCL by malsegregation of chromosomes during anaphase of mitosis. Recently, we showed that centrosome aberrations occur more frequently in tetraploid MCL as compared to their diploid counterparts. To test the hypothesis of an association between tetraploidization and expression of genes coding for centrosomal proteins in MCL, tumor RNA of 33 MCL samples was hybridized to custom-made cDNA microarrays, representing 4,628 distinct human gene-specific fragments, with particular enrichment for cancer-relevant (n = 2,440) and centrosome-associated genes (n = 359). Notably, 4 of the 6 most significant genes (CAMKK2, PCNT2, TUBGCP3, TUBGCP4) discriminating between diploid and near-tetraploid MCL code for centrosomal proteins. As confirmed by quantitative RT-PCR analysis, calcium/calmodulin-dependent protein kinase II (CAMKK2), pericentrin (PCNT2) and gamma-tubulin complex associated protein 3 (TUBGCP3) were all found to be significantly higher expressed in near-tetraploid than in diploid MCL samples. In conclusion, we describe a comprehensive expression signature of a set of genes associated with tetraploidization in MCL. The high expression level of centrosome-associated gene products in blastoid MCL matches the description of more frequent centrosome aberrations in this MCL variant. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236200     DOI: 10.1002/ijc.22404

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Centrosome Aberration Frequency and Disease Association in B-Acute Lymphoblastic Leukemia.

Authors:  Lily S Kerketta; Kanjaksha Ghosh; Anita Nadkarni; Manisha Madkaikar; Babu Rao Vundinti
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

Review 2.  The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).

Authors:  F Nguyen-Khac; A Bidet; A Daudignon; M Lafage-Pochitaloff; G Ameye; C Bilhou-Nabéra; E Chapiro; M A Collonge-Rame; W Cuccuini; N Douet-Guilbert; V Eclache; I Luquet; L Michaux; N Nadal; D Penther; B Quilichini; C Terre; C Lefebvre; M-B Troadec; L Véronèse
Journal:  Leukemia       Date:  2022-04-16       Impact factor: 12.883

3.  Potential effects of CRM1 inhibition in mantle cell lymphoma.

Authors:  Ke-Jie Zhang; Michael Wang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

4.  Recurrent isochromosome 21 and multiple abnormalities in a patient suspected of having acute myeloid leukemia with eosinophilic differentiation -- a rare case from South India.

Authors:  Sangeetha Vijay; Santhi Sarojam; Sureshkumar Raveendran; Vani Syamala; Sreeja Leelakumari; Geetha Narayanan; Sreedharan Hariharan
Journal:  Chin J Cancer       Date:  2011-12-16

Review 5.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

6.  Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis.

Authors:  Alan Fu; Aaron E Hoffman; Ran Liu; Daniel I Jacobs; Tongzhang Zheng; Yong Zhu
Journal:  Epigenetics       Date:  2014-02-06       Impact factor: 4.861

Review 7.  Pericentrin in cellular function and disease.

Authors:  Benedicte Delaval; Stephen J Doxsey
Journal:  J Cell Biol       Date:  2009-12-01       Impact factor: 10.539

8.  Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.

Authors:  Sabrina Ruppenthal; Helga Kleiner; Florian Nolte; Alice Fabarius; Wolf-Karsten Hofmann; Daniel Nowak; Wolfgang Seifarth
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

Review 9.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.